Answer
Octanate LV, as factor VIII replacement therapy, may increase cardiovascular risk in patients with existing cardiovascular risk factors.
Sources for this answer
- OctanateLV 100 IU/mL Powder and solvent for solution for injectionOctapharma Limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 6Document updated
Sources checked